Kenji Yasukawa
Representative Director, Chairman of the Board
Resume, position and responsibilities at the Company
April 1986: Joined the Company
April 2005: Vice President, Project Management, Urology, the Company
June 2010: Corporate Executive of the Company and Therapeutic Area Head, Urology, Astellas Pharma Europe B.V.
October 2010: Corporate Executive of the Company and Therapeutic Area Head, Urology, Astellas Pharma Global Development, Inc.
April 2011: Corporate Executive, Vice President, Product & Portfolio Strategy, the Company
April 2012: Corporate Executive, Chief Strategy Officer (CSTO), the Company
June 2012: Senior Corporate Executive, Chief Strategy Officer (CSTO), the Company
April 2017: Senior Corporate Executive, Chief Strategy Officer and Chief Commercial Officer (CSTO & CCO), the Company
June 2017: Representative Director, Executive Vice President, Chief Strategy Officer and Chief Commercial Officer (CSTO & CCO), the Company
April 2018: Representative Director, President and Chief Executive Officer (CEO), the Company
April 2023: Representative Director, Chairman of the Board, the Company (present post)
March 2024: Outside Board Director, Resonac Holdings Corporation (present post)
Close
Naoki Okamura
Representative Director, President and CEO
Resume, position and responsibilities at the Company
April 1986: Joined the Company
October 2010: President & CEO, OSI Pharmaceuticals, Inc.
April 2012: Senior Vice President, Chief Strategy Officer, Astellas Pharma Europe Ltd.
July 2014: Vice President, Licensing & Alliances, the Company
April 2016: Vice President, Corporate Planning, the Company
June 2016: Corporate Executive, Vice President, Corporate Planning, the Company
April 2018: Corporate Executive, Chief Strategy Officer (CSTO), the Company
April 2019: Corporate Executive Vice President, Chief Strategy Officer (CStO), the Company
June 2019: Representative Director, Executive Vice President, Chief Strategy Officer (CStO), the Company
October 2019: Representative Director, Executive Vice President, Chief Strategy Officer and Chief Financial Officer (CStO & CFO), the Company
September 2021: Representative Director, Executive Vice President, Chief Strategy Officer, Chief Financial Officer and Chief Business Officer (CStO & CFO, and CBO), the Company
March 2022: Representative Director, Executive Vice President, Chief Strategy Officer and Chief Business Officer (CStO and CBO), the Company
April 2022: Representative Director, Executive Vice President and Chief Strategy Officer (CStO), the Company
April 2023: Representative Director, President and Chief Executive Officer (CEO), the Company (present post)Close
Katsuyoshi Sugita
Representative Director, Executive Vice President
Resume, position and responsibilities at the Company
April 1991: Joined Asahi Kasei Corp.
January 2005: Director, Human Resources, Medical Devices, Johnson & Johnson K.K.
November 2008: Vice President, Human Resources, Hilti Japan Ltd.
August 2012: Vice President, Human Resources, AstraZeneca K.K.
July 2016: Senior Director, Human Resources, Microsoft Japan Co., Ltd.
May 2021: Executive Vice President, Human Resources (current Head, Human Resources), the Company (present post)
October 2022: Senior Corporate Executive (Senmu Tantou-Yakuin), Chief People Officer and Chief Ethics & Compliance Officer (CPO & CECO), the Company
June 2023: Representative Director, Executive Vice President, Chief People Officer and Chief Ethics & Compliance Officer (CPO & CECO), the Company (present post)
Close
Takashi Tanaka
Outside Director
Resume, position and responsibilities at the Company
April 1981: Joined Kokusai Denshin Denwa Co., Ltd. (KDD)
April 2003: Executive Officer, General Manager, Solution Product Development Division, Solution Business Sector, KDDI CORPORATION
June 2007: Managing Executive Officer, Executive Director, Solution Business Sector, KDDI CORPORATION
August 2007: President, Wireless Broadband Planning Inc. (current UQ Communications Inc.)
April 2009: Managing Executive Officer, Solution Business Sector, KDDI CORPORATION
April 2010: Managing Executive Officer, Solution Business Sector, Consumer Business Sector, and Product Development Sector, KDDI CORPORATION
June 2010: Senior Managing Executive Officer, Solution Business Sector, Consumer Business Sector, and Product Development Sector, KDDI CORPORATION; Chairman, UQ Communications Inc.
December 2010: Representative Director, President, KDDI CORPORATION
April 2018: Representative Director, Chairman of the Board, KDDI CORPORATION
June 2018: Director, Okinawa Cellular Telephone Company
June 2021: Director, the Company (present post)
June 2024: Director, Chairman of the Board, KDDI CORPORATION
April 2025: Director, Senior Corporate Advisor (non- executive), KDDI CORPORATION
June 2025: Advisor (non- executive), KDDI CORPORATION (present post)
Close
Eriko Sakurai
Outside Director
Resume, position and responsibilities at the Company
June 1987: Joined Dow Corning Corporation (current Dow Silicones Corporation)
March 2009: Chairman and CEO, Representative Director, Dow Corning Toray Co., Ltd. (current Dow Toray Co., Ltd.)
May 2011: Regional President Japan/Korea, Dow Corning Corporation (current Dow Silicones Corporation)
June 2014: Outside Director, Sony Corporation (current Sony Group Corporation)
February 2015: President, Representative Director, Dow Silicones Holdings Japan Kabushiki Kaisha (current Specialty Products Japan Godo Kaisha)
June 2015: Outside Director, Sumitomo Mitsui Financial Group, Inc. (present post)
August 2020: President and Representative Director, Dow Chemical Japan Limited; President, Representative Director, Dow Japan Holdings Kabushiki Kaisha (current Dow Chemical Japan Limited); President, Representative Director, Performance Materials Japan Kabushiki Kaisha
March 2022: Outside Director, Kao Corporation (present post)
June 2022: Director, the Company (present post)
June 2023: External Director, Nippon Sheet Glass Co., Ltd. (present post)Close
Masahiro Miyazaki
Outside Director
Resume, position and responsibilities at the Company
April 1977: Joined Nissei Sangyo Co., Ltd. (current Hitachi High-Tech Corporation)
March 1990: Chief Representative, Kuala Lumpur Representative Office, Nissei Sangyo (Singapore) Pte. Ltd. (current Hitachi High-Tech (Singapore) Pte. Ltd.)
January 1995: General Manager, Electronic Components Div., Nissei Sangyo America, Ltd. (current Hitachi High-Tech America, Inc.)
June 2002: Deputy General Manager, Electronics Div., Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
July 2004: General Manager, Electronics Div., Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
April 2007: Executive Officer, General Manager, Regional Branch Office for West Japan Area and Kansai Branch Office, Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
April 2010: President and CEO, Hitachi High Technologies America, Inc. (current Hitachi High-Tech America, Inc.)
April 2014: Senior Vice President and Executive Officer, General Manager, Corporate Strategy Div., Fine Technology Systems Business Div. and CSO (Chief Strategy Officer), Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
April 2015: Representative Executive Officer, President and Chief Executive Officer, Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
June 2015: Representative Executive Officer, President and Chief Executive Officer and Director., Hitachi High-Technologies Corporation (current Hitachi High-Tech Corporation)
April 2021: Chairman Emeritus, Hitachi High-Tech Corporation
June 2022: Outside Director, Kurita Water Industries Ltd. (present post)
June 2023: Director, the Company (present post)
Close
Yoichi Ohno
Outside Director
Resume, position and responsibilities at the Company
May 1993: Assistant Professor, Internal Medicine, School of Medicine, Keio University
April 1995: Deputy Chief, Internal Medicine, Tokyo Denryoku Hospital
April 2002: Director, Green Town Clinic Center, and Chief, Internal Medicine, Green Town Clinic
July 2005: Chief, Nephrology, Endocrinology and Metabolism Department, Internal Medicine, Saitama City Hospital
April 2007: Senior Lecturer, Nephrology, Saitama Medical University
August 2007: Senior Lecturer, Community Health Science Center, Saitama Medical University
April 2013: Associate Professor, Community Health Science Center and Nephrology, Saitama Medical University
April 2020: Visiting Professor, Social Medicine, Research Administration Center and Medical Education Center, Saitama Medical University (present post)
June 2023: Director, the Company (present post)
Close
Andreas Busch
Outside Director
Resume, position and responsibilities at the Company
October 1997: Head of DG Cardiovascular Diseases, Hoechst Marion Roussel (current Sanofi S.A.)
January 1999: Vice President, Head of DG Cardiovascular Diseases, Aventis (current Sanofi S.A.)
September 2000: Extraordinary Professor of Pharmacology, Goethe University Frankfurt
July 2004: Global Head of Cardiovascular Research, Sanofi- Aventis (current Sanofi S.A.)
May 2005: Senior Vice President, Head of Discovery Europe, Bayer HealthCare AG (current Bayer AG)
January 2016: Head of Drug Discovery, Bayer Pharma AG (current Bayer AG)
January 2018: Head of R&D and CSO, Shire plc
April 2019: Chief Innovation Officer and CSO, Cyclerion Inc. (current Cyclerion Therapeutics Inc.)
February 2022: Non-Executive Director, Centogene N.V. (current Crown LiquidationCo N.V.)
October 2022: Chief Innovation Officer, Absci Corporation (present post)
June 2025: Director, the Company (present post)
Close
Mark Enyedy
Outside Director
Resume, position and responsibilities at the Company
September 1990: Associate, Palmer & Dodge LLP (current Locke Lord LLP)
February 1996: Corporate Counsel, Genzyme Corporation (current Sanofi S.A.)
November 1999: Vice President, Business Development, Oncology, Genzyme Corporation (current Sanofi S.A.)
July 2008: President, Transplant, Oncology and Multiple Sclerosis, Genzyme Corporation (current Sanofi S.A.)
September 2011: Director, Chief Executive Officer, Proteostasis Therapeutics, Inc. (current Janssen Pharmaceutica NV)
July 2012: Non-Executive Director, Fate Therapeutics, Inc.
August 2013: Head of Business Unit, Internal Medicine, Shire plc
May 2014: Head of Corporate Development, Shire plc
May 2016: Director, President and Chief Executive Officer, ImmunoGen Inc. (current AbbVie Inc.)
September 2017: Non-Executive Director, Keryx Biopharmaceuticals, Inc. (current Akebia Therapeutics, Inc.)
March 2020: Non-Executive Director, LogicBio Therapeutics, Inc. (current Alexion Pharmaceuticals, Inc.)
May 2021: Non-Executive Director, Ergomed Group Limited (present post)
December 2023: Non-Executive Director, BioMarin Pharmaceutical Inc. (present post)
June 2025: Director, the Company (present post)
Close
Rika Hirota
Director, Audit & Supervisory Committee Member
Resume, position and responsibilities at the Company
April 1991: Joined the Company
April 2015: Head, Bioscience Research Laboratories, Drug Discovery Research, the Company
April 2017: Head, Research Regulatory Management, Drug Discovery Research, the Company
April 2022: Head, Research Regulation and Administration, Applied Research and Operations, the Company
January 2023: Special Advisor, Audit & Supervisory Committee Office, the Company
April 2023: Head, Audit & Supervisory Committee Office, the Company
April 2024: Report to CEO, the Company
June 2024: Director (Audit & Supervisory Committee Member), the Company (present post)
Close
Mika Nakayama
Outside Director, Audit & Supervisory Committee Member
Resume, position and responsibilities at the Company
August 1984: Joined Nippon Synthetic Rubber Co., Ltd. (current JSR Corporation)
April 2015: Officer, General Manager of Corporate Planning Department and General Manager of Diversity Promotion Office, JSR Corporation
April 2017: Executive Officer, General Manager of Intellectual Property Department, JSR Corporation
June 2020: Director, Senior Officer, General Manager of Sustainability Promotion Dept., JSR Corporation
June 2022: Director (Audit & Supervisory Committee Member), the Company (present post)
June 2024: Outside Director, Mitsubishi Kakoki Kaisha, Ltd. (present post)
Close
Rie Akiyama
Outside Director, Audit & Supervisory Committee Member
Resume, position and responsibilities at the Company
April 1992: Joined Sanwa Bank Ltd. (current MUFG Bank, Ltd.)
April 1999: Registered as attorney-at-law (Tokyo Bar Association)
April 1999: Joined Baba Law Office (current Baba & Sawada Law Office) (present post)
June 2019: Outside Director, GOLDWIN INC. (present post)
June 2023: Director (Audit & Supervisory Committee Member), the Company (present post)
Close
Tomoko Aramaki
Outside Director, Audit & Supervisory Committee Member
Resume, position and responsibilities at the Company
October 1991: Joined Century Audit Corporation (current Ernst & Young ShinNihon LLC) (resigned in October 2001)
March 1995: Registered as Certified Public Accountant
February 2006: President, Aramaki CPA Office (present post)
April 2006: Registered as Certified Tax Accountant
June 2008: Outside Audit & Supervisory Board Member, PARIS MIKI HOLDINGS Inc.
June 2015: Director, in charge of Investor Relations, PARIS MIKI HOLDINGS Inc.
December 2015: Outside Audit & Supervisory Board Member, SACOS CORPORATION
June 2018: Outside Audit & Supervisory Board Member, KYOWA EXEO CORPORATION (current EXEO Group, Inc.)
March 2022: Outside Director, FUJI SOFT INCORPORATED (present post)
June 2023: Outside Director, EXEO Group, Inc. (present post)
June 2023: Outside Director (Audit & Supervisory Committee Member), TRE HOLDINGS CORPORATION (present post)
June 2024: Director (Audit & Supervisory Committee Member), the Company (present post)
Close